Medidata NEXT Conference in Shanghai Unveils Vision for Life Sciences to Accelerate the Development of New Therapies

Event showcases AI and innovative technologies to accelerate the delivery of new therapies to patients

SHANGHAI, China, Sept. 6, 2024– Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has kicked off NEXT Shanghai 2024, the company’s premier life sciences conference. Celebrating its 13th year, the event is unveiling transformative innovations designed to reshape the clinical landscape and deliver next-generation therapies to patients.

Bringing together over 600 life sciences experts from around the world, NEXT Shanghai is helping to highlight the pivotal role of artificial intelligence (AI) and decentralized clinical trials (DCT) in the future of clinical development. The conference features presentations from industry thought leaders, such as Tony Guo, Ph.D. from BeiGene, and Prof. Li Jin from Shanghai GoBroad Cancer Hospital China Pharmaceutical University.

The event also includes interactive sessions and immersive experiences, which provide participants with hands-on opportunities to engage with the latest technologies. Attendees can explore innovation booths, simulate trial experiences, and interact with advanced data management systems from the perspective of patients, sponsors, sites, and contract research organizations (CROs), gaining valuable insights into how they can engage with and conduct clinical trials.

“We are bringing together industry leaders at NEXT Shanghai and marking Medidata’s 25th anniversary with a keynote from Medidata CEO Anthony Costello,” said Wei (Jennifer) Li, vice president and general manager, Greater China, Medidata. “Through our partnerships with over 600 customers and CROs, we have supported more than 3,000 trials in China. We remain dedicated to advancing AI and DCT technologies to improve R&D efficiency and accelerate the delivery of life-changing treatments to patients worldwide.”

Additionally, Medidata has partnered with other Dassault Systèmes brands, such as BIOVIA and SIMULIA, to showcase a comprehensive portfolio of digital solutions for the life sciences industry at NEXT Shanghai. This year’s event highlights innovations with BIOVIA applications in drug discovery, laboratory quality management, and manufacturing and quality improvement, along with SIMULIA applications in medical devices.

NEXT Shanghai is a key stop in the annual Medidata NEXT global event series, showcasing nearly 30 presentations throughout the day.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.